Access cutting-edge type 2 diabetes mellitus (t2dm) treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Portland location
Preparing your pre-screening questions…
Access type 2 diabetes mellitus (t2dm) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 2 diabetes mellitus (t2dm) treatment provided free
Check if you qualify for this type 2 diabetes mellitus (t2dm) clinical trial in Portland, OR
No-Cost Study Care
Local to Portland
Convenient for OR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant complications in type 2 diabetes pregnancies. The main questions it aims to answer are: 1. Does continuous glucose monitoring improve infant outcomes compared to self-monitoring of blood glucose? 2. Does continuous glucose monitoring improve maternal diabetes control and other maternal outcomes compared to self-monitoring of blood glucose? 3. What other factors increase the risk of maternal and infant complications? Participants will: 1. Use continuous glucose monitoring or self-monitoring of blood glucose to monitor blood sugar control from enrollment until delivery 2. Have blood drawn at enrollment, 24 weeks, 34 weeks and delivery to measure hemoglobin A1c levels and store blood for future analysis 3. Complete surveys about social support, environmental stressors, diabetes distress and glucose monitoring satisfaction at research visits 4. Have umbilical cord blood collected at delivery for analysis
Sponsor: University of Alabama at Birmingham
Yes, this clinical trial (NCT06628453) has an active research site in Portland, OR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for type 2 diabetes mellitus (t2dm) treatment options in Portland, OR, this clinical trial (NCT06628453) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 2 diabetes mellitus (t2dm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all type 2 diabetes mellitus (t2dm) clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Portland — not just this study.
Browse Pulmonary Embolism Trials in Portland →